| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |